The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease

Chronic inflammation drives the development of atherosclerosis. Despite optimal treatment of classical cardiovascular risk factors, a substantial portion of the population has elevated inflammatory biomarkers and develops atherosclerosis-related complications, indicating that a residual inflammatory...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Cardiovasc Transl Res
Main Authors: Bosmans, Laura A., Bosch, Lena, Kusters, Pascal J.H., Lutgens, Esther, Seijkens, Tom T.P.
Format: Artigo
Jezik:Inglês
Izdano: Springer US 2020
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7892683/
https://ncbi.nlm.nih.gov/pubmed/32222950
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12265-020-09994-3
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki